Philip Morris International Inc
NYSE:PM 1:59:58 PM EDT
Regulatory, Earnings Announcements
Philip Morris International Announces U.S. Food And Drug Administration Authorization Of Iqos 3 For Sale In The United States
Published: 12/07/2020 22:33 GMT
Philip Morris International Inc (PM) - Philip Morris International Announces U.S. Food and Drug Administration Authorization of Iqos 3 for Sale in the United States.
Philip Morris International Inc - Expects to File an Application Seeking a Modified Exposure Marketing Order for Iqos 3 Device.
Philip Morris International Inc - Expects to File an Application Seeking a Modified Exposure Marketing Order for Iqos 3 Device.
Revenue is expected to be $8 Billion
Adjusted EPS is expected to be $1.34
Next Quarter Revenue Guidance is expected to be $8.77 Billion
Next Quarter EPS Guidance is expected to be $1.58
More details on our Analysts Page.
Adjusted EPS is expected to be $1.34
Next Quarter Revenue Guidance is expected to be $8.77 Billion
Next Quarter EPS Guidance is expected to be $1.58
More details on our Analysts Page.